Gastroduodenal mucosal defense

Current Opinion in Gastroenterology

Volumn 25, Issue 6, 2009, Pages 537-543

  Nayeb Hashemia, Hamed ^a   Kaunitz, Jonathan D ^a,b,c,d  

^a UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Brentwood Biomedical Research Institute Los Angeles   (United States)

Author keywords

Bicarbonate; Defense; Duodenum; Gastric; Helicobacter pylori

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ANTIPORTER; BICARBONATE; ESTROGEN DERIVATIVE; GHRELIN; LANSOPRAZOLE; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN; NEUROPEPTIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OREXIN; OREXIN A; PEROXIREDOXIN; PROTON PUMP INHIBITOR; TOLL LIKE RECEPTOR; TREFOIL PEPTIDE; VASCULOTROPIN; VIRULENCE FACTOR;

ANION EXCHANGE; CELLULAR IMMUNITY; DEFENSE MECHANISM; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG MECHANISM; DRUG MEGADOSE; DUODENUM INJURY; DUODENUM MUCOSA; ENZYME PHOSPHORYLATION; HELICOBACTER INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE MUCOSA PERMEABILITY; OXIDATIVE STRESS; PEPTIC ULCER; PORTAL HYPERTENSIVE GASTROPATHY; REGULATORY T LYMPHOCYTE; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STOMACH DISEASE; STOMACH INJURY; STOMACH MUCOSA; STOMACH MUCOSA LESION; STOMACH PROTECTION; STOMACH ULCER; T LYMPHOCYTE; ULCER HEALING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BICARBONATES; DUODENUM; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; IMMUNITY, MUCOSAL; LOTUS; MUCINS; NEUROPEPTIDES; OXIDATIVE STRESS; PEPTIC ULCER; PHOSPHORYLATION; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74549165582     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328330da7b     Document Type: Review

References (39)

1. Allen A, Flemström G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 2005; 288:C1-C19.
2. Walker NM, Simpson JE, Brazill JM, et al. Role of down-regulated in adenoma anion exchanger in HCO3-secretion across murine duodenum. Gastroenterology 2009; 136:893-901.
3. 2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 2009; 296:G424-G432. Description of ecto-purinergic regulation of duodenal bicarbonate secretion.
4. Hirokawa M, Takeuchi T, Chu S, et al. Cystic fibrosis gene mutation reduces epithelial cell acidification and injury in acid-perfused mouse duodenum. Gastroenterology 2004; 127:1162-1173.
5. 2 exposure in rat duodenal mucosa. Am J Physiol Gastrointest Liver Physiol 2008; 294:G1318-G1327.
6. Smith A, Contreras C, Ko KH, et al. Gender specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion. Endocrinol 2008; 149:4554-4566. Well performed mechanistic study of the effect of estrogens on duodenal bicarbonate secretion performed in mice.
7. Shimozawa N, Okajima K, Harada N. Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats. Am J Physiol Gastrointest Liver Physiol 2007; 292:G615-G619.
8. Ichikawa Y, Tarnawski A, Sarfeh IJ, et al. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats. Gastroenterology 1994; 106:702-708.
9. Kinjo N, Kawanaka H, Akahoshi T, et al. Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications. Am J Physiol Gastrointest Liver Physiol 2008; 295:G1016-G1024.
10. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl 1999; 56:18-24.
11. Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009; 104:728-738.
12. Maity P, Bindu S, Choubey V, et al. Lansoprazole protects and heals gastric mucosa from nonsteroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J Biol Chem 2008; 283: 14391-14401. In-depth study of the mechanism of lanzoprazole gastroprotection possibly unrelated to its antisecretory properties.
13. Uejima M, Kinouchi T, Kataoka K, et al. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol 1996; 40:553-560.
14. Watanabe T, Higuchi K, Kobata A, et al. Nonsteroidal anti-inflammatory druginduced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57:181-187. NSAID-induced small intestinal damage may be modified by innate immune responses including toll-like receptor signaling.
15. Kruse MN, Mallory BS, Noto H, et al. Properties of the descending limb of the spinobulbospinal micturition reflex pathway in the cat. Brain Res 1991; 556:6-12.
16. Oshima T, Miwa H, Joh T. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am J Physiol Cell Physiol 2008; 295:C800-C806. Describes a unique and well described mechanism gastric injury from aspirin via tight junction disruption.
17. Joh T, Takezono Y, Oshima T, et al. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells. Aliment Pharmacol Ther 2003; 18 (Suppl 1):133-138.
18. Sibilia V, Rindi G, Pagani F, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144:353-359.
19. Sibilia V, Pagani F, Rindi G, et al. Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk. Br J Pharmacol 2008; 154:688-697. Interesting study on the interrelations between ghrelin, COX activity, the nitric oxide pathway, and gastroprotection.
20. Bengtsson MW, Makela K, Sjoblom M, et al. Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A. Am J Physiol Gastrointest Liver Physiol 2007; 293: G501-G509.
21. Bülbül M, Tan R, Gemici B, et al. Effect of orexin-a on ischemia-reperfusioninduced gastric damage in rats. J Gastroenterol 2008; 43:202-207. Orexin-A exhibits a gastroprotective effect by decreasing neutrophil activation and lipid peroxidation.
22. Brzozowski T, Konturek PC, Sliwowski Z, et al. Gastroprotective action of orexin-A against stress-induced gastric damage is mediated by endogenous prostaglandins, sensory afferent neuropeptides and nitric oxide. Regul Pept 2008; 148:6-20. Another study on the gastroprotective effects of orexin invoking well described protective mechanisms.
23. Rad R, Brenner L, Bauer S, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131:525-537.
24. Robinson K, Kenefeck R, Pidgeon EL, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008; 57:1375-1385. Insightful and original study of the connection between Helicobacter pylori infection and ulcer diseases invoking the immune system.
25. Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008; 134:491-499. Another study relating to H. pylori infection-related ulcer disease to the immune system.
26. Clyne M, Dillon P, Daly S, et al. Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc Natl Acad Sci U S A 2004; 101: 7409-7414.
27. Vinall LE, King M, Novelli M, et al. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 2002; 123:41-49.
28. Reeves EP, Ali T, Leonard P, et al. Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology 2008; 135:2043-2054; 2054. Helicobacter pylori binding to TFF1 occurs in a pH dependent manner possibly acting a secreted decoy molecule preventing bacterial adhesion to gastric epithelial cells.
29. Schreiber S, Konradt M, Groll C, et al. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci U S A 2004; 101:5024-5029.
30. McGuckin MA, Every AL, Skene CD, et al. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 2007; 133:1210-1218.
31. Sato D, Yanaka A, Shibahara T, et al. Peroxiredoxin;1; I protects gastric mucosa from oxidative injury induced by H. pylori infection. J Gastroenterol Hepatol 2008; 23:652-659. Peroxiredoxin upregulation in H. pylori infection plays a gastroprotective role by reduction in oxidative injury.
32. Mita M, Satoh M, Shimada A, et al. Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model. Am J Physiol Gastrointest Liver Physiol 2008; 294:G877-G884. Metallothionein prevents H. pylori-induced gastric erosions by neutralization of ROS.
33. Wroblewski LE, Shen L, Ogden S, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology 2009; 136:236-246. Helicobacter pylori alters membrane-bound occludins leading to disruption of gastric epithelial integrity.
34. Tuo B, Song P, Wen G, et al. Helicobacter pylori vacuolating cytotoxin inhibits duodenal bicarbonate secretion by a histamine-dependent mechanism in mice. J Infect Dis 2009; 199:505-512. Another means by which H. pylori can impair mucosal defensive mechanisms.
35. Ki MR, Lee HR, Goo MJ, et al. Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008; 294:G635-G647.
36. Kim YS, Park SW, Kim MH, et al. Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers. J Gastroenterol Hepatol 2008; 23 (Suppl 2):S131-S139. Describes a novel VEGF gene polymorphism associated with increased risk of gastroduodenal ulcers and decreased transcriptional activity and angiogenesis.
37. Dudar GK, D'Andrea LD, Di SR, et al. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner. Am J Physiol Gastrointest Liver Physiol 2008; 295:G374-G381. Well performed study of the effect of VEGF on experimental ulcer healing.
38. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
39. Epple HJ, Schneider T, Troeger H, et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009; 58:220-227. HIV infection alters tight junction protein composition leading to increased intestinal permeability. Treatment with antiretrovirals appears to restore intestinal barrier integrity.